Company attributes
B2X
CEO
Legal Name
Chameleon Biosciences Inc.
Legal classification
Number of Employees (Ranges)
1 – 10
Phone Number
+14146613146
Full Address
626 Bancroft Way Suite A Berkeley, CA 94710 United States0
Total Funding Amount (USD)
3,100,000
Latest Funding Round Date
March 2019
Latest Funding Type
Country
Other attributes
Company Operating Status
Active
Chameleon Biosciences Inc. is a gene therapy company that provides a first-in-class vector platform technology for lowering the immune response that is associated with gene therapy treatments. Chameleon has a goal of transforming gene therapy.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
